Arvee LaboratoriesARVEE 
3.38%24h
Arvee Laboratories (ARVEE) Stock Overview
Arvee Laboratories (India) Ltd. manufactures and sells various specialized chemicals in India. The company provides polymer modifiers, including dimethyl 5-sodiosulfoisophthalate, 5-sulfoisophthalic acid mono sodium salt, 5-sulfoisophthalic acid mono lithium salt, and 5-sodiosulfo-bis-(ß-hydroxyethyl)-isophthalate; and contrast media intermediates, such as 5-nitroisophthalic acid, dimethyl 5-nitroisophthalate, monomethyl 5-nitroisophthalate, 5-hydroxyisophthalic acid, 5-aminoisophthalic acid, and dimethyl 5-aminoisophthalate, as well as 3,5-dinitrobenzoic acid and 3,5-diamino benzoic acid. It also offers drug intermediates comprising 2-acetyl thiophene, thiophene-2-carboxaldehyde, 4amino pyridine, and 2chloro5nitrobenzoic acid. In addition, the company exports its products. Arvee Laboratories (India) Ltd. was incorporated in 2012 and is based in Ahmedabad, India.
ARVEE Stock Information
Arvee Laboratories (ARVEE) Price Chart
Arvee Laboratories Overview: Key Details and Summary
Stock data | 2023 | Change |
|---|---|---|
| Price | $2.18 | N/A |
| Market Cap | $24.04M | N/A |
| Shares Outstanding | 11.02M | 0.00% |
| Employees | 67.00 | N/A |
| Shareholder Equity | 280.62M | 17.21% |
Valuation | 2023 | Change |
|---|---|---|
| P/E Ratio | 0.58 | N/A |
| P/S Ratio | 3.29 | N/A |
| P/B Ratio | 0.09 | N/A |
Growth | 2023 | Change |
|---|---|---|
| Return on Equity | 0.0017 | N/A |
Earnings | 2023 | Change |
|---|---|---|
| Revenue | $7.30M | N/A |
| Earnings | $491.03K | N/A |
| EPS | 3.74 | N/A |
| Earnings Yield | 1.71 | N/A |
| Gross Margin | 0.2825 | N/A |
| Operating Margin | 0.0855 | N/A |
| Net income margin | 0.0672 | N/A |
Financial Strength | 2023 | Change |
|---|---|---|
| Total Assets | $4.61M | N/A |
| Total Debt | $119.21K | N/A |
| Cash on Hand | $106.90K | N/A |
| Debt to Equity | 0.0045 | -38.52% |
| Cash to Debt | 0.8967 | -9.66% |
| Current Ratio | $2.44 | 46.33% |
